Literature DB >> 22266776

Self-reported history of infections and the risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.

Nikolaus Becker1, Michael O Falster, Claire M Vajdic, Silvia de Sanjose, Otoniel Martínez-Maza, Paige M Bracci, Mads Melbye, Karin Ekström Smedby, Eric A Engels, Jennifer Turner, Paolo Vineis, Adele Seniori Costantini, Elizabeth A Holly, John J Spinelli, Carlo La Vecchia, Tongzhang Zheng, Brian C-H Chiu, Maurizio Montella, Pierluigi Cocco, Marc Maynadié, Lenka Foretova, Anthony Staines, Paul Brennan, Scott Davis, Richard Severson, James R Cerhan, Elizabeth C Breen, Brenda Birmann, Wendy Cozen, Andrew E Grulich, Robert Newton.   

Abstract

We performed a pooled analysis of data on self-reported history of infections in relation to the risk of non-Hodgkin lymphoma (NHL) from 17 case-control studies that included 12,585 cases and 15,416 controls aged 16-96 years at recruitment. Pooled odds ratios (OR) and 95% confidence intervals (95% CI) were estimated in two-stage random-effect or joint fixed-effect models, adjusting for age, sex and study centre. Data from the 2 years before diagnosis (or date of interview for controls) were excluded. A self-reported history of infectious mononucleosis was associated with an excess risk of NHL (OR = 1.26, 95% CI = 1.01-1.57 based on data from 16 studies); study-specific results indicate significant (I(2) = 51%, p = 0.01) heterogeneity. A self-reported history of measles or whooping cough was associated with an approximate 15% reduction in risk. History of other infection was not associated with NHL. We find little clear evidence of an association between NHL risk and infection although the limitations of data based on self-reported medical history (particularly of childhood illness reported by older people) are well recognized.
Copyright © 2012 UICC.

Entities:  

Mesh:

Year:  2012        PMID: 22266776      PMCID: PMC3406230          DOI: 10.1002/ijc.27438

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  23 in total

1.  Medical history and risk of Hodgkin's and non-Hodgkin's lymphomas.

Authors:  A Tavani; C La Vecchia; S Franceschi; D Serraino; A Carbone
Journal:  Eur J Cancer Prev       Date:  2000-02       Impact factor: 2.497

2.  Risk of Hodgkin's disease and other cancers after infectious mononucleosis.

Authors:  H Hjalgrim; J Askling; P Sørensen; M Madsen; N Rosdahl; H H Storm; S Hamilton-Dutoit; L S Eriksen; M Frisch; A Ekbom; M Melbye
Journal:  J Natl Cancer Inst       Date:  2000-09-20       Impact factor: 13.506

3.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

Review 4.  Altered immunity as a risk factor for non-Hodgkin lymphoma.

Authors:  Andrew E Grulich; Claire M Vajdic; Wendy Cozen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03-02       Impact factor: 4.254

5.  Haematopoietic cancer and medical history: a multicentre case control study.

Authors:  P Vineis; P Crosignani; C Sacerdote; A Fontana; G Masala; L Miligi; O Nanni; V Ramazzotti; S Rodella; E Stagnaro; R Tumino; C Viganò; C Vindigni; A S Costantini
Journal:  J Epidemiol Community Health       Date:  2000-06       Impact factor: 3.710

6.  A comparison of pregnancy history recall and medical records. Implications for retrospective studies.

Authors:  B C Tilley; A B Barnes; E Bergstralh; D Labarthe; K L Noller; T Colton; E Adam
Journal:  Am J Epidemiol       Date:  1985-02       Impact factor: 4.897

Review 7.  Overview of the epidemiology of immunodeficiency-associated cancers.

Authors:  V Beral; R Newton
Journal:  J Natl Cancer Inst Monogr       Date:  1998

8.  Population-based study of non-Hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco.

Authors:  Elizabeth A Holly; Paige M Bracci
Journal:  Am J Epidemiol       Date:  2003-08-15       Impact factor: 4.897

9.  Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women.

Authors:  Yawei Zhang; Theodore R Holford; Brian Leaderer; Shelia Hoar Zahm; Peter Boyle; Lindsay McOmber Morton; Bing Zhang; Kaiyong Zou; Stuart Flynn; Giovanni Tallini; Patricia H Owens; Tongzhang Zheng
Journal:  Cancer Causes Control       Date:  2004-05       Impact factor: 2.506

10.  Tobacco and alcohol consumption and the risk of non-Hodgkin lymphoma.

Authors:  Eleanor V Willett; Alexandra G Smith; Gareth J Dovey; Gareth J Morgan; Jan Parker; Eve Roman
Journal:  Cancer Causes Control       Date:  2004-10       Impact factor: 2.506

View more
  12 in total

1.  Common immune-related exposures/conditions and risk of non-Hodgkin lymphoma: a case-control study of disease-discordant twin pairs.

Authors:  Jun Wang; Thomas M Mack; Ann S Hamilton; Amie E Hwang; Bharat N Nathwani; Kamil Masood; Laura H Buchanan; Leslie Bernstein; Dennis M Deapen; Otoniel Martínez-Maza; Wendy Cozen
Journal:  Am J Epidemiol       Date:  2015-08-12       Impact factor: 4.897

2.  Investigation of epstein-barr virus as a potential cause of B-cell non-Hodgkin lymphoma in a prospective cohort.

Authors:  Anneclaire J De Roos; Otoniel Martínez-Maza; Keith R Jerome; Dana K Mirick; Kenneth J Kopecky; Margaret M Madeleine; Larry Magpantay; Kerstin L Edlefsen; Andrea Z Lacroix
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-07-24       Impact factor: 4.254

3.  Pericardial involvement as an initial presentation of anaplastic large cell lymphoma.

Authors:  Purushothaman Muthusamy; Stephen Ebrom; Stephen D Cohle; Nasir Khan
Journal:  Can Fam Physician       Date:  2014-07       Impact factor: 3.275

4.  Epidemiology of Marginal Zone Lymphoma.

Authors:  James R Cerhan; Thomas M Habermann
Journal:  Ann Lymphoma       Date:  2021-03-30

5.  Childhood infectious diseases and risk of multiple myeloma: an analysis of the Italian multicentre case-control study.

Authors:  E Stagnaro; S Parodi; A Seniori Costantini; P Crosignani; L Miligi; O Nanni; S Piro; V Ramazzotti; S Rodella; R Tumino; C Vindigni; P Vineis
Journal:  Epidemiol Infect       Date:  2018-05-30       Impact factor: 4.434

6.  Risk of lymphoma subtypes by occupational exposure in Southern Italy.

Authors:  Giuseppe Ingravallo; Chiara Monica Guastadisegno; Maria Luisa Congedo; Gianfranco Lagioia; Maria Cristina Loparco; Annamaria Giordano; Tommasina Perrone; Francesco Gaudio; Caterina Spinosa; Carla Minoia; Lucia D'Onghia; Michela Strusi; Vincenzo Corrado; Domenica Cavone; Luigi Vimercati; Nunzia Schiavulli; Giovanni Maria Ferri; Giorgina Specchia; Patrizio Mazza; Graziana Intranuovo; Pierluigi Cocco
Journal:  J Occup Med Toxicol       Date:  2017-11-23       Impact factor: 2.646

7.  Current understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological update.

Authors:  Bryan A Bassig; Qing Lan; Nathaniel Rothman; Yawei Zhang; Tongzhang Zheng
Journal:  J Cancer Epidemiol       Date:  2012-09-12

8.  Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL): an InterLymph Consortium study.

Authors:  Niquelle Brown Wadé; Cindy M Chang; David Conti; Joshua Millstein; Christine Skibola; Alexandra Nieters; Sophia S Wang; Silvia De Sanjose; Eleanor Kane; John J Spinelli; Paige Bracci; Yawei Zhang; Susan Slager; Jun Wang; Henrik Hjalgrim; Karin Ekstrom Smedby; Elizabeth E Brown; Ruth F Jarrett; Wendy Cozen
Journal:  Cancer Causes Control       Date:  2020-03-02       Impact factor: 2.532

9.  Programmed cell death 1 expression and Epstein-Barr virus infection in chronic lymphocytic leukaemia: a prospective cohort study.

Authors:  Ewelina Grywalska; Marcin Pasiarski; Barbara Sosnowska-Pasiarska; Paweł Macek; Agnieszka Rolińska; Marzena Samardakiewicz; Jarosław Ludian; Stanisław Góźdź; Jacek Roliński
Journal:  Cancer Manag Res       Date:  2019-08-12       Impact factor: 3.989

10.  Common infection-related conditions and risk of lymphoid malignancies in older individuals.

Authors:  L A Anderson; A A Atman; C M McShane; G J Titmarsh; E A Engels; J Koshiol
Journal:  Br J Cancer       Date:  2014-04-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.